최훈지 교수
학력
서울대학교 의학대학원 서울대학교 대학원 내과학 박사 |
경력
서울대학교병원 수련의 분당서울대학교병원 내과 전공의 서울대학교병원 내분비대사내과 임상강사 서울대학교병원 내분비대사내과 연구임상강사 한림대학교동탄성심병원 내분비내과 진료조교수 한림대학교동탄성심병원 내분비내과 임상조교수 한림대학교동탄성심병원 내분비내과 조교수 |
학회활동
대한당뇨병학회 대한내분비학회 대한지질동맥경화학회 대한비만학회 대한골대사학회 |
수상이력
2017 ~ 2019Best Resident (Department of Internal Medicine) Award of the year 2020Poster presentation (Top 10 Poster Award) ㅡ 17th Asia-Oceania Congress of Endocrinology and the 8th Seoul International Congress of Endocrinology and Metabolism 2021Best plenary oral presentation award ㅡ 9th Seoul International Congress of Endocrinology and Metabolism in conjunction with the 40th Annual Scientific Meeting of Korean Endocrine Society (SICEM 2021) 2022Best metaverse poster presentation award ㅡ 35th Annual meeting of the Korean Diabetes Association (KDA 2022 2022Young Investigator bursary ㅡ The European Association for the Study of the Liver (EASL) 2023DMJ International Publication Award ? 36th Annual meeting of the Korean Diabetes Association (KDA 2023) 2023Best oral presentation award ? 2023 International Congress on Obesity and MEtabolic Syndrome hosted by KSSO (ICOMES 2023) 2024Young Investigator bursary ? The European Association for the Study of the Liver (EASL) 2024Best poster presentation award ? 2024 Symposium for Academia, Research, and Industry & Autumn Congress of the Korean Endocrine Society 20252024 Metabolism Award for Junior Faculty Members 2025Best Guided Poster Presentation Award ? 2025 International Congress Obesity and MEtabolic Syndrome hosted by KSSO (ICOMES 2025) 2026KDA Rising Star |
논문/저서
|
1) 논문 (주저자) 1.IJE-2025-11-2110.R2 Ten and thirty-year cardiovascular disease risks using PREVENT equation in Koreans from 2001 to 2021 (accepted 2026-05-15) 2. DMJ – midthigh fat (LDM on DM) 3. Choe HJ, Kwak MK, Lee JW, Choi YM, Hong EG. Comparative Clinical Analysis of DPP-4 inhibitors and SGLT2 Inhibitors: A Real-World Switch Study. J Obes Metab Syndr 2026;35(2):237–246. DOI: 10.7570/jomes25049. 4. Choe HJ*, Do Han K*, Park JH, et al. Underweight Status Amplifies Respiratory Infection Mortality in Diabetes: Findings From a Nationwide Cohort Study. J Cachexia Sarcopenia Muscle 2026;17(2):e70263. DOI: 10.1002/jcsm.70263. 5. Park HW, Choe HJ*, Lim HJ, et al. Metabolic Impact of Sodium-Glucose Cotransporter 2 Inhibitor-Induced Ketogenesis in Type 2 Diabetes Mellitus. J Obes Metab Syndr 2026;35(2):211–221. DOI: 10.7570/jomes25062. 6. Choe HJ*, Almas T*, Neeland IJ, Lim S, Despres JP. Obesity phenotypes and atherogenic dyslipidemias. Eur J Clin Invest 2026;56(1):e70151. DOI: 10.1111/eci.70151. 7. Choe HJ, Despres JP, Wilding JPH, Ryan DH, Lim S. Clinical and Preclinical Obesity in Korean Adults from 2014 to 2023. Diabetes Metab J 2026;50(1):127–138. DOI: 10.4093/dmj.2025.0697. 8. Choe HJ*, Han KD*, Park JH, et al. Underweight and Mortality in Type 2 Diabetes: A Nationwide Retrospective Cohort Study. J Cachexia Sarcopenia Muscle 2025;16(6):e70145. DOI: 10.1002/jcsm.70145. 9. Bae JH*, Choe HJ*, Yang YS, Seo MH, Choi JH, Kim G, Lyu YS, Han JH, Kang S, Kim WJ, Kim KS, Cho YM, Cha BS; Severe Diabetes Mellitus Task Force of the Korean Diabetes. Defining Severe Diabetes Mellitus: A Consensus Framework for Grading and Staging Diabetes Based on Pathophysiology and Complications. Diabetes Metab J. 2025 Nov;49(6):1141-1154. DOI: 10.4093/dmj.2025.0739. Epub 2025 Oct 28. PMID: 41153071. 10. Choe HJ, Hong EG. Rapid Glycemic Correction and the Paradox of Retinopathy Progression. Endocrinol Metab (Seoul). 2025 Oct;40(5):702-705. DOI: 10.3803/EnM.2025.2696. PMID: 41208265. 11. Choe HJ, Lee JS, Park JY, Lee SA, Park YJ, Chung SS, Park KS. SENP2 regulates UCP1-dependent thermogenesis in brown adipocytes via deSUMOylation of ERRα. Exp Mol Med. 2025 Jun;57(6):1283-1293. DOI: 10.1038/s12276-025-01458-5. PMID: 40579429. 12. Choe HJ, Choi YM, Ha Y, et al. The Role of the Parametric Thyroid Feedback Quantile Index in Cardiovascular Risk Evaluation Among Euthyroid Koreans. J Clin Endocrinol Metab 2025. DOI: 10.1210/clinem/dgaf046. PMID: 39842874. 13. Choe HJ, Nauck MA, Moon JH. Metabolic Consequences of Glucagon-Like Peptide-1 Receptor Agonist Shortage: Deterioration of Glycemic Control in Type 2 Diabetes. Endocrinol Metab (Seoul) 2025;40(1):156-160. DOI: 10.3803/EnM.2024.2150. PMID: 39582250. 14. Choe HJ*, Ko YH*, Moon SJ*, Ahn CH, Ha KH, Lee H, Bae JH, Joo HJ, Lee H, Son JW, Kim DJ, Kim SG, Kim K, Cho YM. Financial Benefits of Renal Dose-Adjusted Dipeptidyl Peptidase-4 Inhibitors for Patients with Type 2 Diabetes and Chronic Kidney Disease. Endocrinol Metab (Seoul). 2024 Aug;39(4):622-631. doi: 10.3803/EnM.2024.1965. Epub 2024 Aug 1. PMID: 39086276; PMCID: PMC11375300. 15. Choe HJ*, Moon JH*, Kim W*, Koo BK, Cho NH. Steatotic liver disease predicts cardiovascular disease and advanced liver fibrosis: A community-dwelling cohort study with 20-year follow-up. Metabolism. 2024 Apr;153:155800. doi: 10.1016/j.metabol.2024.155800. Epub 2024 Jan 22. PMID: 38266957. 16. Moon JH*, Choe HJ*, Lim S. Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes. J Diabetes Investig. 2024 Jun;15(6):669-683. doi: 10.1111/jdi.14221. Epub 2024 Apr 27. PMID: 38676410; PMCID: PMC11143426 17. Choe HJ, Oh HR, Bu D, An N, Scherer PE, An Z, Lim S. Evaluation of the efficacy of a combination of dapagliflozin and lobeglitazone on glucose concentrations and body fat in patients with type 2 diabetes: Location-F study. Diabetes Obes Metab. 2024 Mar;26(3):1114-1119. doi: 10.1111/dom.15388. Epub 2023 Dec 11. PMID: 38073421. 18. Choe HJ, Chang W, Blüher M, Heymsfield SB, Lim S. Independent association of thigh muscle fat density with vascular events in Korean adults. Cardiovasc Diabetol. 2024 Jan 28;23(1):44. doi: 10.1186/s12933-024-02138-w. PMID: 38281946; PMCID: PMC10823598. 19. Choe HJ, Lee H, Lee D, Kwak SH, Koo BK. Different effects of low muscle mass on the risk of non-alcoholic fatty liver disease and hepatic fibrosis in a prospective cohort. J Cachexia Sarcopenia Muscle. 2023 Feb;14(1):260-269. doi: 10.1002/jcsm.13125. Epub 2022 Nov 20. 20. Choe HJ*, Rhee EJ*, Won JC*, Park KS, Lee WY, Cho YM. Effects of Patient-Driven Lifestyle Modification Using Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: Results From the Randomized Open-label PDF Study. Diabetes Care. 2022;45:2224-2230. doi: 10.2337/dc22-0764 21. Choe HJ, Cho BL, Park YS, Roh E, Kim HJ, Lee SG, Kim BJ, Kim M, Won CW, Park KS, Jang HC. Gender differences in risk factors for the 2 year development of sarcopenia in community-dwelling older adults. J Cachexia Sarcopenia Muscle 2022;13:1908-1918. DOI: 10.1002/jcsm.12993. 22. Bae JH*, Choe HJ*, Holick MF, Lim S. Association of vitamin D status with COVID-19 and its severity : Vitamin D and COVID-19: a narrative review. Rev Endocr Metab Disord 2022;23:579-599. DOI: 10.1007/s11154-021-09705-6. 23. Moon SJ*, Choe HJ*, Kwak SH, Jung HS, Park KS, Cho YM. Comparison of Prevailing Insulin Regimens at Different Time Periods in Hospitalized Patients: A Real-World Experience from a Tertiary Hospital. Diabetes Metab J 2022;46:439-450. DOI: 10.4093/dmj.2021.0065. 24. Choe HJ, Park S, Han KD, Moon MK, Koo BK. Contribution of hypertriglyceridemia to ischemic cardiovascular disease in Korean Women: A nationwide population-based study. J Clin Lipidol 2022;16:83-93. DOI: 10.1016/j.jacl.2021.11.008. 25. Choe HJ, Koo BK, Yi KH, et al. Skeletal effects of combined bisphosphonates treatment and parathyroidectomy in osteoporotic patients with primary hyperparathyroidism. J Bone Miner Metab 2022;40:292-300. DOI: 10.1007/s00774-021-01279-2. 26. Choe HJ, Cho YM. Invincible beta-cells in type 1 diabetes. J Diabetes Investig 2021;12(2):137-139. DOI: 10.1111/jdi.13362. 27. Choe HJ, Cho YM. Peptidyl and Non-Peptidyl Oral Glucagon-Like Peptide-1 Receptor Agonists. Endocrinol Metab (Seoul) 2021;36(1):22-29. DOI: 10.3803/EnM.2021.102. 28. Choe HJ, Suh KJ, Lee JY, et al. Acute pulmonary thromboembolism caused by factor V Leiden mutation in South Korea: A case report. Medicine (Baltimore) 2019;98(28):e16318. DOI: 10.1097/MD.0000000000016318. 29. Choe HJ, Kim JW, Han SH, et al. Conversion Surgery in Metastatic Gastric Cancer and Cancer Dormancy as a Prognostic Biomarker. Cancers (Basel) 2019;12(1). DOI: 10.3390/cancers12010086. 30. Choe HJ, Ahn S, Jung K, Kim JW. Acute liver failure caused by occupational exposure to HCFC-123: Two case reports. Medicine (Baltimore) 2019;98(9):e14522. DOI: 10.1097/MD.0000000000014522. 31. Choe HJ, Choe BH. What physicians should know about the management of chronic hepatitis B in children: East side story. World J Gastroenterol 2014;20(13):3582-9. DOI: 10.3748/wjg.v20.i13.3582. 2) 논문 (공저자) 1. Fibro-inflammatory liver injury, not steatosis, predicts incident composite neuropsychiatric events and mortality in the UK Biobank, Metabolism (accepted 2026-05-13) 2. Tioh JK, Ho GJK, Than EKJ, Hieda S, Yang HS, Rekhi R, Chan TYH, Muthia MD, Takahashi H, Mohammad SS, Moon JH, Choe HJ, Huang W, et al. Prevalence, Trends, and Mortality of Low Muscle Mass and Its Association With Metabolic Diseases in the United States Population. JCSM Communications 2026;9:370039. DOI: 10.1002/rco2.70039. 3. Jang Y, Lee JH, Lee SG, Choe, HJ, et al. A Position Paper on Lipoprotein(a) From the Lipoprotein(a) Task Force of the Korean Society of Lipid and Atherosclerosis: Current Evidence, Clinical Applications, and Future Directions. J Lipid Atheroscler 2026;15(1):2–25. DOI: 10.12997/jla.2026.15.1.2. PMID: 41660526. 4. Jang Y, Lee JH, Lee SG, Choe, HJ, et al. A Position Paper on Lipoprotein(a) From the Lipoprotein(a) Task Force of the Korean Society of Lipid and Atherosclerosis: Current Evidence, Clinical Applications, and Future Directions. Korean Circ J 2026;56(1):9–32. DOI: 10.4070/kcj.2025.0388. PMID: 41560299. 5. Park JH, Han K, Choe HJ, et al. Underweight and cardiovascular risk in Type 2 diabetes: a Korean nationwide study. Eur Heart J 2025. DOI: 10.1093/eurheartj/ehaf903. PMID: 41288350. 6. Choi JH, Kang S, Kim SK, Kim WJ, Kim JM, Bae J, Yun JS, Jeon E, Kim YE, Bae JH, Choe HJ, et al. Bridging Evidence and Practice: A Consensus Statement from the Korean Diabetes Association on Diabetes Screening, Pharmacological Treatment and Severe Diabetes. Diabetes Metab J 2025;49(6):1155–1177. DOI: 10.4093/dmj.2025.0978. PMID: 41243295. 7. Choi W, Moon JH, Choe HJ, et al. Longitudinal insights into the natural history of Type 2 diabetes among Koreans: A 20-year community-based prospective cohort study. J Intern Med 2025;298(4):336–348. DOI: 10.1111/joim.70010. PMID: 40855982. 8. Son H, Sohn SH, Kim HA, Choe HJ, et al. Real-time continuous glucose monitoring improves postoperative glucose control in people with type 2 diabetes mellitus undergoing coronary artery bypass grafting: A randomized clinical trial. Diabetes Obes Metab 2025;27(4):1836–1844. DOI: 10.1111/dom.16177. PMID: 39776241 9. Kim YH, Yoon JW, Lee BH, Yoon JH, Choe HJ, et al. Artificial intelligence-based body composition analysis using computed tomography images predicts both prevalence and incidence of diabetes mellitus. J Diabetes Investig 2025;16(2):272–284. DOI: 10.1111/jdi.14365. PMID: 39576146. 10. Lee JS, Min JE, Choe HJ, Park KS, Chung SS. SUMO-specific protease 2 regulates lipid droplet size through ERRalpha-mediated CIDEA expression in adipocytes. Biochem Biophys Res Commun 2023;681:29–35. DOI: 10.1016/j.bbrc.2023.09.052. PMID: 37748256. |